GE Healthcare Korea and DeepCardio said Tuesday they signed an agreement to jointly develop AI-based electrocardiogram (ECG) diagnosis technology and an ECG data analysis program.The two companies will combine GE Healthcare’s ECG data management system MUSE and DeepCardio’s AI technology in ECG to d
Boditech Med said it obtained the regulatory nod for ichorma Vitamin D Neo, a diagnostic device that can detect Vitamin-D deficiency in blood in 12 minutes.The device’s identification of Vitamin D levels within 12 minutes at a medical institution will reduce the inconvenience of patients who otherwi
Medtronic Korea held a press conference on Thursday to introduce the top five winners of the “Medtronic APAC Innovation Challenge (MAIC),” announced on March 16 in Singapore.The challenge was participated by 323 startups and companies from 46 countries in the Asia-Pacific region.The five winners are
New drug development using artificial intelligence (AI) has become a major trend in the global pharmaceutical industry, but some question the feasibility of such efforts.Industry officials said AI would help save cost and time for drug development and raise the chance of commercialization. Yet, no A
Korean drugmakers expressed regrets on Wednesday that there are no biopharmaceutical experts in President-elect Yoon Suk-yeol’s transition team.As the nation has experienced the Covid-19 pandemic for more than two years, the importance of the biopharmaceutical sector in dealing with infectious disea
Ildong Bioscience said on Monday it exported its probiotics to Thailand for the first time in the company’s history.The Korean company recently signed an agreement with Thailand’s Milott Laboratories to supply probiotics and completed the shipping of the first batch of 600,000 units.Milott Laborator
Daewoong Pharmaceutical said it would team up with KB Biomed to develop an oral osteoporosis treatment.On Friday, Daewoong said it signed a joint development and license agreement with KB Biomed for synthetic or recombinant peptides of teriparatide, an osteoporosis drug. The two companies plan to de
The Ministry of Food and Drug Safety said it would work with seven private and public institutions to intensely monitor marketing sites on the internet until December to root out the illegal online sale of medicines and narcotics.The seven groups are the Korean Pharmaceutical Association, Korea Phar
LSK Global Pharma Services, a contract research organization (CRO), said it established an academic research service (ARS) unit on Thursday.The ARS team will provide services needed for academic research in the medical and pharmaceutical research area, including research planning, study design, data
Olympus Korea held a news conference on Thursday to announce the market release of EndoBRAIN-EYE, an AI-backed colonoscopy diagnosis support system.However, the new AI technology has to overcome many challenges to be used by clinicians in the field, industry watchers said.EndoBRAIN-EYE is assistant
Ildong Pharmaceutical said Wednesday it released a new hyaluronic acid filler Hyaleve Series and began full-scale marketing.Hyaleve Series is a medical device for tissue repair and wrinkle improvement. The treatment contains a non-animal and sterile hyaluronic acid derivative, which was obtained thr
RedHill Biopharma, an Israel-based biopharmaceutical firm, said Wednesday that it signed an exclusive license agreement with Kukbo, a Korean company, for opaganib, an oral Covid-19 treatment.Under the agreement, RedHill will receive a $1.5 upfront payment and up to $5.6 million in milestone payments
L&K Biomed said on Monday it obtained FDA approval for PathLoc-TM, a next-generation height-expandable spinal implant product for the treatment of spinal diseases.PathLoc-TM is used in the posterior and posterolateral positions, where the procedure is most frequently performed in spinal implants.Acc
“In the not-too-distant future, there will be a cloud-based general hospital that operates beyond borders. Medical education, research, and clinical trials will take place in this space. This seems to be the future of healthcare.”Jheon Sang-hoon, a professor of thoracic and cardiovascular surgery at
Seegene, a multiplex molecular diagnostics company, said Thursday that it has developed a diagnostic reagent that can identify the Covid-19 infection in 30 minutes.Seegene’s new product, Allplex SARS-CoV-2 fast MDx Assay, has obtained the Conformity European In-Vitro Diagnostics (CE-IVD) marking. Th
“As a pharmaceutical company that makes drugs directly affecting Korean people’s health, we will walk on the right path with unwavering faith.”So said Korea United Pharm CEO Kang Duk-young at a group interview with health journalists where he evaluated the company’s performance last year and shared
The International Vaccine Institute (IVI) said the Ministry of Health and Welfare had been named it to operate “2022 Global Bio-Intensive Training Courses,” a Korean government program.IVI will provide workforce training in vaccine and biologics R&D and manufacturing for people from low- and middle-
A Korean research team proposed a detailed classification method based on cancer stem cell RNA characteristics and customized, targeted therapy for intractable hepatocellular carcinoma (HCC) that does not respond to existing treatments.The research team, led by professor Lee Sung-hwan at the Departm
The government granted health insurance benefits for Bausch Health Korea’s glaucoma treatment Vyzulta Eye Drops 0.024% (ingredient: latanoprostene bunod), and Kolon Pharma’s psoriasis treatment Skilarence Enteric Coated Tab. 120mg (dimethyl fumarate) from February.Also, the government expanded the r
AbbVie said its drug Skyrizi (ingredient: risankizumab) obtained the U.S. FDA authorization to treat adults with active psoriatic arthritis (PsA).The FDA approval was based on the results of the KEEPsAKE-1 and KEEPsAKE-2 trials which tested Skyrizi in adults with PsA, including those who had respond